These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 8836336

  • 1. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
    Brostoff J, Fitzharris P, Dunmore C, Theron M, Blondin P.
    Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L, Murrieta Aguttes M, Tonet J.
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [Abstract] [Full Text] [Related]

  • 3. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group.
    Leynadier F, Duarte-Risselin C, Murrieta M.
    Eur J Dermatol; 2000 Jan; 10(3):205-11. PubMed ID: 10725819
    [Abstract] [Full Text] [Related]

  • 4. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
    Frèche C, Leynadier F, Horak F, Hide D, Gracia FD, Goos M, Bachert C, Horvath A, Antosova E, Verrecchia M, Soussen PB.
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J, Nagy G, Tóth A, Spellenberg S, Schwarz M, Répassy G.
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
    Pons-Guiraud A, Nekam K, Lahovsky J, Costa A, Piacentini A.
    Eur J Dermatol; 2006 Jan; 16(6):649-54. PubMed ID: 17229605
    [Abstract] [Full Text] [Related]

  • 12. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
    Kapp A, Pichler WJ.
    Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 14. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.
    Lorette G, Giannetti A, Pereira RS, Leynadier F, Murrieta-Aguttes M.
    J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):83-90. PubMed ID: 10972091
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F.
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
    Belaich S, Bruttmann G, DeGreef H, Lachapelle JM, Paul E, Pedrali P, Tennstedt D.
    Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
    [Abstract] [Full Text] [Related]

  • 20. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, Lahfa M, Pérez I, Izquierdo I, Arnaiz E.
    Eur J Dermatol; 2007 Feb; 17(3):223-8. PubMed ID: 17478385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.